dystroglycan Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of dystroglycan monoclonal antibodies for investigating dystroglycan's role in various biological processes. Dystroglycan monoclonal antibodies are compatible with multiple experimental techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Dystroglycan is a critical component of the dystrophin-glycoprotein complex, playing a vital role in connecting the extracellular matrix to the cytoskeleton of muscle cells. It is essential for maintaining muscle integrity and function, and its dysregulation has been implicated in various muscular dystrophies and other diseases. Understanding dystroglycan's function and interactions is crucial for developing therapeutic strategies for these conditions. Dystroglycan monoclonal antibodies enable detailed analysis of protein expression patterns across different tissue types and experimental conditions. Researchers can utilize dystroglycan monoclonal antibodies to examine cellular localization, protein-protein interactions, and expression levels in normal and pathological states. Advanced research techniques supported by dystroglycan monoclonal antibodies include protein quantification, signaling pathway analysis, and structural studies. Santa Cruz Biotechnology monoclonal antibodies for dystroglycan research continue to support scientific advancement in understanding muscular dystrophies and related disorders.